Scopia Capital Management 13F holdings, Q2 2019
Holdings as of June 30, 2019 · filings on SEC EDGAR · latest filing →
Scopia Capital Management disclosed 22 US equity positions worth $1.9bn in its Q2 2019 13F filing. The largest position was VST at 13.8% of the reported book, followed by S9Q and ITRI. Against the Q1 2019 filing, it opened 7 new positions, added to 6 and reduced 8 among the top 22 holdings.
What did Scopia Capital Management own in Q2 2019? Top 22 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2019 |
|---|---|---|---|---|---|---|---|
| 1 | VST VISTRA ENERGY CORP | Utilities | 13.8% | $266.9m | 11,788,503 | -11% | reduced |
| 2 | S9Q SPIRIT AEROSYSTEMS HLDGS INC | 10.8% | $208.7m | 2,564,326 | 12% | added | |
| 3 | ITRI ITRON INC | Technology | 10.6% | $204.0m | 3,260,227 | -30% | reduced |
| 4 | JCI JOHNSON CTLS INTL PLC | Industrials | 8.6% | $165.7m | 4,010,813 | -42% | reduced |
| 5 | EQUITRANS MIDSTREAM CORPORAT | 6.9% | $133.7m | 6,783,588 | -19% | reduced | |
| 6 | SPIRIT RLTY CAP INC NEW | 6.0% | $115.0m | 2,695,324 | 4% | added | |
| 7 | HORIZON THERAPEUTICS PUB LTD | 5.3% | $103.2m | 4,288,487 | – | new | |
| 8 | VONAGE HLDGS CORP | 5.1% | $99.3m | 8,762,269 | 1% | added | |
| 9 | WELBILT INC | 5.0% | $96.3m | 5,764,889 | 178% | added | |
| 10 | IAA INC | 4.7% | $89.9m | 2,318,366 | – | new | |
| 11 | NXPI NXP SEMICONDUCTORS N V | Technology | 4.5% | $87.3m | 894,704 | – | new |
| 12 | RETROPHIN INC | 4.0% | $78.0m | 3,884,691 | -8% | reduced | |
| 13 | ZOGENIX INC | 3.5% | $68.1m | 1,424,247 | -25% | reduced | |
| 14 | OPLN KAR AUCTION SVCS INC | Consumer Cyclical | 3.3% | $64.1m | 2,565,615 | 144% | added |
| 15 | PTCT PTC THERAPEUTICS INC | Healthcare | 2.3% | $44.2m | 983,005 | -53% | reduced |
| 16 | HEADHUNTER GROUP PLC | 1.8% | $35.5m | 2,186,732 | – | new | |
| 17 | HLIT HARMONIC INC | Technology | 1.8% | $33.8m | 6,092,937 | 112% | added |
| 18 | ACORDA THERAPEUTICS INC | 1.3% | $25.5m | 3,323,456 | -25% | reduced | |
| 19 | FOSL FOSSIL GROUP INC | Consumer Cyclical | 0.2% | $4.6m | 395,925 | – | new |
| 20 | INTERCEPT PHARMACEUTICALS IN | 0.2% | $4.5m | 56,794 | – | new | |
| 21 | MNKD MANNKIND CORP | Healthcare | 0.1% | $1.1m | 933,612 | – | new |
| 22 | AMSC AMERICAN SUPERCONDUCTOR CORP | Industrials | 0.0% | $182.0k | 19,610 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.